✦ LIBER ✦

Comprehensive therapeutic outcomes of frontline imatinib mesylate in newly diagnosed chronic phase chronic myeloid leukemia patients in Korea: feasibility assessment of current ELN recommendation

✍ Scribed by Kim, Dongho; Goh, Hyun Gyung; Kim, Soo-Hyun; Choi, Soo-Young; Park, Sa-Hee; Jang, Eun-Jung; Kim, Dong-Wook

Book ID: 113099317
Publisher: Carden Jennings Publishing
Year: 2012
Tongue: English
Weight: 600 KB
Volume: 96
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-012-1093-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The long-term clinical implications of c

The long-term clinical implications of clonal chromosomal abnormalities in newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib mesylate

✍ Sung-Eun Lee; Soo Young Choi; Ju-Hee Bang; Soo-Hyun Kim; Eun-jung Jang; Ji-Young 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 436 KB

Chromosomal abnormalities in Philadelphi

Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase

✍ Jabbour, E.; Kantarjian, H. M.; Abruzzo, L. V.; O'Brien, S.; Garcia-Manero, G.; 📂 Article 📅 2007 🏛 American Society of Hematology 🌐 English ⚖ 117 KB

Phase III, Randomized, Open-Label Study

Phase III, Randomized, Open-Label Study of Daily Imatinib Mesylate 400 mg Versus 800 mg in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase Using Molecular End Points: Tyrosine Kinase Inhibitor Optimization and Selectivity Study

✍ Cortes, J. E.; Baccarani, M.; Guilhot, F.; Druker, B. J.; Branford, S.; Kim, D.- 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 166 KB